BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 19567624)

  • 1. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.
    Hellquist A; Järvinen TM; Koskenmies S; Zucchelli M; Orsmark-Pietras C; Berglind L; Panelius J; Hasan T; Julkunen H; D'Amato M; Saarialho-Kere U; Kere J
    J Rheumatol; 2009 Aug; 36(8):1631-8. PubMed ID: 19567624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.
    Järvinen TM; Hellquist A; Koskenmies S; Einarsdottir E; Koskinen LL; Jeskanen L; Berglind L; Panelius J; Hasan T; Ranki A; Kere J; Saarialho-Kere U
    Exp Dermatol; 2010 Feb; 19(2):123-31. PubMed ID: 19758313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.
    Tang L; Wan P; Wang Y; Pan J; Wang Y; Chen B
    Inflamm Res; 2015 Oct; 64(10):817-24. PubMed ID: 26294277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of interaction between systemic lupus erythematosus-associated polymorphisms in TYK2 and IRF5.
    Suarez-Gestal M; Calaza M; Gonzalez A
    J Rheumatol; 2010 Mar; 37(3):676-7; author reply 678. PubMed ID: 20197570
    [No Abstract]   [Full Text] [Related]  

  • 5. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
    Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
    Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population.
    Järvinen TM; Hellquist A; Zucchelli M; Koskenmies S; Panelius J; Hasan T; Julkunen H; D'Amato M; Kere J
    Rheumatology (Oxford); 2012 Jan; 51(1):87-92. PubMed ID: 22039224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between tyrosine kinase 2 (TYK2) gene polymorphisms and susceptibility to SLE in a Japanese population.
    Kyogoku C; Morinobu A; Nishimura K; Sugiyama D; Hashimoto H; Tokano Y; Mimori T; Terao C; Matsuda F; Kuno T; Kumagai S
    Mod Rheumatol; 2009; 19(4):401-6. PubMed ID: 19440814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus.
    Hu W; Ren H
    Int J Immunogenet; 2011 Oct; 38(5):411-7. PubMed ID: 21834935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
    Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
    Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposed independent effects and epistasis in the complex association of IRF5 to SLE.
    Ferreiro-Neira I; Calaza M; Alonso-Perez E; Marchini M; Scorza R; Sebastiani GD; Blanco FJ; Rego I; Pullmann R; Pullmann R; Kallenberg CG; Bijl M; Skopouli FN; Mavromati M; Migliaresi S; Barizzone N; Ruzickova S; Dostal C; Schmidt RE; Witte T; Papasteriades C; Kappou-Rigatou I; Endreffy E; Kovacs A; Ordi-Ros J; Balada E; Carreira P; Gomez-Reino JJ; Gonzalez A
    Genes Immun; 2007 Jul; 8(5):429-38. PubMed ID: 17568788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts.
    Nordang GB; Viken MK; Amundsen SS; Sanchez ES; Flatø B; Førre OT; Martin J; Kvien TK; Lie BA
    Rheumatology (Oxford); 2012 Apr; 51(4):619-26. PubMed ID: 22179739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.
    Kyogoku C; Dijstelbloem HM; Tsuchiya N; Hatta Y; Kato H; Yamaguchi A; Fukazawa T; Jansen MD; Hashimoto H; van de Winkel JG; Kallenberg CG; Tokunaga K
    Arthritis Rheum; 2002 May; 46(5):1242-54. PubMed ID: 12115230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The analysis on single nucleotide polymorphism of PDCD1 and systemic lupus erythematous susceptibility among Han indigenous in Chinese population].
    Ye DQ; Yin J; Li XP; Zhang GQ; Zhang YQ; Wang Q; Liu HH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Sep; 26(9):698-701. PubMed ID: 16471222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus.
    Velázquez-Cruz R; Orozco L; Espinosa-Rosales F; Carreño-Manjarrez R; Solís-Vallejo E; López-Lara ND; Ruiz-López IK; Rodríguez-Lozano AL; Estrada-Gil JK; Jiménez-Sánchez G; Baca V
    Eur J Hum Genet; 2007 Mar; 15(3):336-41. PubMed ID: 17228327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families.
    Cunninghame Graham DS; Akil M; Vyse TJ
    Rheumatology (Oxford); 2007 Jun; 46(6):927-30. PubMed ID: 17384181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.
    Zervou MI; Dorschner JM; Ghodke-Puranik Y; Boumpas DT; Niewold TB; Goulielmos GN
    Gene; 2017 Apr; 610():9-14. PubMed ID: 28185859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
    Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
    Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
    Graham RR; Kozyrev SV; Baechler EC; Reddy MV; Plenge RM; Bauer JW; Ortmann WA; Koeuth T; González Escribano MF; ; Pons-Estel B; Petri M; Daly M; Gregersen PK; Martín J; Altshuler D; Behrens TW; Alarcón-Riquelme ME
    Nat Genet; 2006 May; 38(5):550-5. PubMed ID: 16642019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
    Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
    Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.